Abstract
The deacylation-reacylation cycle is an important mechanism responsible for the introduction of polyunsaturated fatty acids into neural membrane glycerophospholipids. It involves four enzymes, namely acyl-CoA synthetase, acyl-CoA hydrolase, acyl-CoA: lysophospholipid acyltransferase, and phospholipase A2. All of these enzymes have been purified and characterized from brain tissue. Under normal conditions, the stimulation of neural membrane receptors by neurotransmitters and growth factors results in the release of arachidonic acid from neural membrane glycerophospholipids. The released arachidonic acid acts as a second messenger itself. It can be further metabolized to eicosanoids, a group of second messengers involved in a variety of neurochemical functions. A lysophospholipid, the second product of reactions catalyzed by phospholipase A2, is rapidly acylated with acyl-CoA, resulting in the maintenance of the normal and essential neural membrane glycerophospholipid composition. However, under pathological situations (ischemia), the overstimulation of phospholipase A2 results in a rapid generation and accumulation of free fatty acids including arachidonic acid, eicosanoids, and lipid peroxides. This results in neural inflammation, oxidative stress, and neurodegeneration. In neural membranes, the deacylation-reacylation cycle maintains a balance between free and esterified fatty acids, resulting in low levels of arachidonic acid and lysophospholipids. This is necessary for not only normal membrane integrity and function, but also for the optimal activity of the membrane-bound enzymes, receptors, and ion channels involved in normal signal-transduction processes.
Similar content being viewed by others
References
Abe T., Fujino T., Fukuyama R., Minoshima S., Shimizu N., Toh H., et al. (1992) Human long-chain acyl-CoA synthetase: structure and chromosomal location. J. Biochem. (Tokyo) 111, 123–128.
Anderson A. D. and Erwin V. G. (1971) Brain acyl-coenzyme A hydrolase: distribution, purification and properties. J. Neurochem. 18, 1179–1186.
Balsinde J., Bianco I. D., Ackermann E. J., Conde-Frieboes K., and Dennis E. A. (1995) Inhibition of calcium-independent phospholipase A2 prevents arachidonic acid incorporation and phospholipid remodeling in P388D1 macrophages. Proc. Natl. Acad. Sci. USA 92, 8527–8531.
Brophy P. J. and Vance D. E. (1976) The synthesis and hydrolysis of long-chain fatty acyl-coenzyme A thioesters by soluble and microsomal fractions from the brain of the developing rat. Biochem. J. 160, 247–251.
Cao Y., Traer E., Zimmerman G. A., McIntyre T. M., and Prescott S. M. (1998) Cloning, expression, and chromosomal localization of human long-chain fatty acid-CoA ligase 4 (FACL4). Genomics 49, 327–330.
Clark J. D., Schievella A. R., Nalefski E. A., and Lin L.-L. (1995) Cytosolic phospholipase A2. J. Lipid Mediat. Cell Signal. 12, 83–117.
Corbin D. R. and Sun G. Y. (1978) Characterization of the enzymic transfer of arachidonoyl groups to 1-acyl-phosphoglycerides in mouse synaptosome fraction. J. Neurochem. 30, 77–82.
Deeney J. T., Tornheim K., Korchak H. M., Prentki M., and Corkey B. E. (1992) Acyl-CoA esters modulate intracellular Ca2+ handling by permeabilized clonal pancreatic β-cells. J. Biol. Chem. 267, 19,840–19,845.
Deka N., Sun G. Y., and MacQuarrie R. (1986) Purification and properties of acyl-CoA: 1-acyl-snglycero-3-phosphocholine-O-acyltransferase from bovine brain microsomes. Arch. Biochem. Biophys. 246, 554–563.
Dumuis A., Sebben M., Haynes L., Pin J.-P., and Bockaert J. (1988) NMDA receptors activate the arachidonic acid cascade system in striatal neurons. Nature 336, 68–70.
Farooqui A. A., Pendley C. E., II, Taylor W. A., and Horrocks L. A. (1985) Studies on diacylglycerol lipases and lysophospholipases of bovine brain., in Phospholipids in the Nervous System, Vol. II: Physiological Role (Horrocks L. A., Kanfer J. N., and Porcellati G., eds.), Raven Press, New York, NY, pp. 179–192.
Farooqui A. A., Hirashima Y., and Horrocks L. A. (1992) Brain phospholipases and their role in signal transduction. Adv. Exp. Med. Biol. 318, 11–25.
Farooqui A. A. and Horrocks L. A. (1994) Excitotoxicity and neurological disorders: involvement of membrane phospholipids. Intl. Rev. Neurobiol. 36, 267–323.
Farooqui A. A., Yang H. C., Rosenberger T. A., and Horrocks L. A. (1997) Phospholipase A2 and its role in brain tissue. J. Neurochem. 69, 889–901.
Farooqui A. A. and Horrocks L. A. (1998) Plasmalogen-selective phospholipase A2 and its involvement in Alzheimer’s disease. Biochem. Soc. Trans. 26, 243–246.
Farooqui A. A., Litsky M. L., Farooqui T., and Horrocks L. A. (1999) Inhibitors of intracellular phospholipase A2 activity: their neurochemical effects and therapeutical importance for neurological disorders. Brain Res. Bull. 49, 139–153.
Farrooqui A. A., Horrocks L. A., and Farroqui T. (2000a) Neural membrane glycerophospholipids: Their metabolism, incorporation into membranes, functions, and involvement in neurological disorders. Chem. Phys. Lipids, (in press).
Farooqui A. A., Ong W. Y., Horrocks L. A., and Farooqui T. (2000b) Brain cytosolic phospholipase A2: localization, role, and involvement in neurological diseases. Neuroscientist (in press).
Fujino T. and Yamamoto T. (1992) Cloning and functional expression of a novel long-chain acyl-CoA synthetase expressed in brain. J. Biochem. (Tokyo) 111, 197–203.
Glick B. S. and Rothman J. E. (1987) Possible role for fatty acyl-coenzyme A in intracellular protein transport. Nature 326, 309–312.
Grand R. J. (1989) Acylation of viral and eukaryotic proteins. Biochem. J. 258, 625–638.
Hashmi M., Stanley W., and Singh I. (1986) Lignoceroyl-CoASH ligase: enzyme defect in fatty acid beta-oxidation system in X-linked childhood adrenoleukodystrophy. FEBS Lett. 196, 247–250.
Hayakawa M., Ishida N., Takeuchi K., Shibamoto S., Hori T., Oku N., et al. (1993) Arachidonic acid-selective cytosolic phospholipase A2 is crucial in the cytotoxic action of tumor necrosis factor. J. Biochem. 268, 11,290–11,295.
Hirashima Y., Farooqui A. A., Mills J. S., and Horrocks L. A. (1992) Identification and purification of calcium-independent phospholipase A2 from bovine brain cytosol. J. Neurochem. 59, 708–714.
Horrocks L. A. and Yeo Y. K. (1999) Health benefits of docosahexaenoic acid (DHA). Pharmacol. Res. 40, 211–225.
Huang W. H., Wang Y., and Askari A. (1989) Mechanism of the control of (Na+ + K+)-ATPase by long-chain acyl coenzyme A. J. Biol. Chem. 264, 2605–2608.
Ikeda M., Yoshida S., Busto R., Santiso M., and Ginsberg M. D. (1986) Polyphosphoinositides as a probable source of brain free fatty acids accumulated at the onset of ischemia. J. Neurochem. 47, 123–132.
Jayadev S., Hayter H. L., Andrieu N., Gamard C. J., Liu B., Balu R., et al. (1997) Phospholipase A2 is necessary for tumor necrosis factor α-induced ceramide generation in L929 cells. J. Biol. Chem. 272, 17,196–17,203.
Jones C. R., Arai T., and Rapoport S. I. (1997) Evidence for the involvement of docosahexaenoic acid in cholinergic stimulated signal transduction at the synapse. Neurochem. Res. 22, 663–670.
Jonsson J. J., Renieri A., Gallagher P. G., Kashtan C. E., Cherniske E. M., Bruttini M., et al. (1998) Alport syndrome, mental retardation, midface hypoplasia, and elliptocytosis: a new X linked contiguous gene deletion syndrome? J. Med. Genet. 35, 273–278.
Katsuki H. and Okuda S. (1995) Arachidonic acid as a neurotoxic and neurotrophic substance. Prog. Neurobiol. 46, 607–636.
Lands W. E. M. (1960) Metabolism of glycerolipids. J. Biol. Chem. 235, 2233–2237.
Lawrence J. B., Moreau P., Cassagne C., and Morre D. J. (1994) Acyl transfer reactions associated with cis Golgi apparatus of rat liver. Biochim. Biophys. Acta 1210, 146–150.
Li Q. L., Yamamoto N., Inoue A., and Morisawa S. (1990) Fatty acyl-CoAs are potent inhibitors of the nuclear thyroid hormone receptor in vitro. J. Biochem. (Tokyo) 107, 699–702.
Lin A. Y., Sun G. Y., and MacQuarrie R. (1984) Partial purification and properties of long-chain acyl-CoA hydrolase from rat brain cytosol. Neurochem. Res. 9, 1571–1591.
MacDonald J. I. S. and Sprecher H. (1991) Phospholipid fatty acid remodeling in mammalian cells. Biochim. Biophys. Acta 1084, 105–121.
Mandrup S., Hummel R., Ravn S., Jensen G., Andreasen P. H., Gregersen N., et al. (1992) Acyl-CoA-binding protein/diazepam-binding inhibitor gene and pseudogenes. A typical housekeeping gene family. J. Mol. Biol. 228, 1011–1022.
McLean L. R., Hagaman K. A., and Davidson W. S. (1993) Role of lipid structure in the activation of phospholipase A2 by peroxidized phospholipids. Lipids 28, 505–509.
Moriyama T., Urade R., and Kito M. (1999) Purification and characterization of diacylglycerol lipase from human platelets. J. Biochem. (Tokyo) 125, 1077–1085.
Ojima A., Nakagawa Y., Sugiura T., Masuzawa Y., and Waku K. (1987) Selective transacylation of 1-O-alkylglycerophosphoethanolamine by docosahexaenoate and arachidonate in rat brain microsomes. J. Neurochem. 48, 1403–1410.
Ong W. Y., Horrocks L. A., and Farooqui A. A. (1999) Distribution of cytoplasmic phospholipase A2 in the normal rat brain. J. Brain Res. 39, 391–400.
Pete M. J. and Exton J. H. (1996) Purification of a lysophospholipase from bovine brain that selectively deacylates arachidonoyl-substituted lysophosphatidylcholine. J. Biol. Chem. 271, 18,114–18,121.
Piccini M., Vitelli F., Bruttini M., Pober B. R., Jonsson J. J., Villanova M., et al. (1998) FACL4, a new gene encoding long-chain acyl-CoA synthetase 4, is deleted in a family with Alport syndrome, elliptocytosis, and mental retardation. Genomics 47, 350–358.
Pirianov G., Danielsson C., Carlberg C., James S. Y., and Colston K. W. (1999) Potentiation by vitamin D analogs of TNFα and ceramide-induced apoptosis in MCF-7 cells is associated with activation of cytosolic phospholipase A2. Cell Death Differ. 6, 890–901.
Prentki M. and Corkey B. E. (1996) Are the beta-cell signaling molecules malonyl-CoA and cystolic long-chain acyl-CoA implicated in multiple tissue defects of obesity and NIDDM? Diabetes 45, 273–283.
Ramanadham S., Hsu F. F., Bohrer A., Ma Z. M., and Turk J. (1999) Studies of the role of group VI phospholipase A2 in fatty acid incorporation, phospholipid remodeling, lysophosphatidylcholine generation, and secretagogue-inducecd arachidonic acid release in pancreatic islets and insulinoma cells. J. Biol. Chem. 274, 13,915–13,927.
Rapoport S. I. (1999) In vivo fatty acid incorporation into brain phospholipids in relation to signal transduction and membrane remodeling. Neurochem. Res. 24, 1403–1415.
Reddy P. V. and Bazan N. G. (1983) Kinetic properties of arachidonoyl-coenzyme A synthetase in rat brain microsomes. Arch. Biochem. Biophys. 226, 125–133.
Reddy T. S. and Bazan N. G. (1984) Long-chain acyl coenzyme A synthetase activity during the post-natal development of the mouse brain. Intl. J. Devel. Neurosci. 2, 447–450.
Reddy T. S. and Bazan N. G. (1987) Arachidonic acid, stearic acid, and diacylglycerol accumulation correlates with the loss of phosphatidylinositol 4,5-bisphosphate in cerebrum 2 seconds after electroconvulsive shock: complete reversion of changes 5 minutes after stimulation. J. Neurosci. Res. 18, 449–455.
Reddy T. S., Sprecher H., and Bazan N. G. (1984) Long-chain acyl-coenzyme A synthetase from rat brain microsomes. Kinetic studies using [1-14C]docosahexaenoic acid substrate. Eur. J. Biochem. 145, 21–29.
Rehncrona S., Westerberg E., Akesson B., and Siesjö B. K. (1982) Brain cortical fatty acids and phospholipids during and following complete and severe incomplete ischemia. J. Neurochem. 38, 84–93.
Reynolds L. J., Hughes L. L., Louis A. I., Kramer R. M., and Dennis E. A. (1993) Metalion and salt effects on the phospholipase A2, lysophospholipase, and transacylase activities of human cytosolic phospholipase A2. Biochim. Biophys. Acta 1167, 272–280.
Ross B. M., Kim D. K., Bonventre J. V., and Kish S. J. (1995) Characterization of a novel phospholipase A2 activity in human brain. J. Neurochem. 64, 2213–2221.
Ross B. M. and Kish S. J. (1994) Characterization of lysophospholipid metabolizing enzymes in human brain. J. Neurochem. 63, 1839–1848.
Ross B. M., Moszczynska A., Erlich J., and Kish S. J. (1998) Phospholipid-metabolizing enzymes in Alzheimer’s disease: increased lysophospholipid acyltransferase activity and decreased phospholipase A2 activity. J. Neurochem. 70, 786–793.
Singh I., Bhuskan A. S., Relan N. K., and Hashimoto T. (1988) Acyl-CoAligase from rat brain microsome: an immunochemical study. Biochim. Biophys. Acta 963, 509–514.
Stephenson D., Rash K., Smalstig B., Roberts E., Johnstone E., Sharp J., et al. (1999) Cytosolic phospholipase A2 is induced in reactive glia following different forms of neurodegeneration. Glia 27, 110–128.
Sun G. Y. and MacQuarrie R. A. (1989) Deacylation-reacylation of arachidonoyl groups in cerebral phospholipids. Ann. NY Acad. Sci. 559, 37–55.
Sun G. Y. and Su K. L. (1979) Metabolism of arachidonoyl phosphoglycerides in mouse brain sucellular fractions. J. Neurochem. 32, 1053–1059.
Surette M. E., Fonteh A. N., Bernatchez C., and Chilton F. H. (1999) Perturbations in the control of cellular arachidonic acid levels block cell growth and induce apoptosis in HL-60 cells. Carcinogenesis 20, 757–763.
Surette M. E., Winkler J. D., Fonteh A. N., and Chilton F. H. (1996) Relationship between arachidonate-phospholipid remodeling and apoptosis. Biochemistry 35, 9187–9196.
Suzuki H., Kawarabayasi Y., Kondo J., Abe T., Nishikawa K., Kimura S., et al. (1990) Structure and regulation of rat long-chain acyl-CoA synthetase. J. Biol. Chem. 265, 8681–8685.
Tomoda H., Igarashi K., Cyong J. C., and Omura S. (1991) Evidence for an essential role of long chain acyl-CoA synthetase in animal cell proliferation. Inhibition of long chain acyl-CoA synthetase by triacsins caused inhibition of Raji cell proliferation. J. Biol. Chem. 266, 4214–4219.
Tone O., Miller J. C., Bell J. M., and Rapoport S. I. (1987) Regional cerebral palmitate incorporation following transient bilateral carotid occlusion in awake gerbils. Stroke 18, 1120–1127.
van Kuijk F. J. G. M., Sevanian A., Handelman G. J., and Dratz E. A. (1987) A new role for phospholipase A2: protection of membranes from lipid peroxidation damage. Trends Biochem. Sci. 12, 3 1–34.
Voelkel-Johnson C., Thorne T. E., and Laster S. M. (1996) Susceptibility to TNF in the presence of inhibitors of transcription or translation is dependent on the activity of cytosolic phospholipase A2 in human melanoma tumor cells. J. Immunol. 156, 201–207.
Wakabayashi S., Freed L. M., Bell J. M., and Rapoport S. I. (1994) In vivo cerebral incorporation of radio-labeled fatty acids after acute unilateral orbital enucleation in adult hooded Long-Evans rats. J. Cereb. Blood Flow Metab. 14, 312–323.
Washizaki K., Smith Q. R., Rapoport S. I., and Purdon A. D. (1994) Brain arachidonic acid incorporation and precursor pool specific activity during intravenous infusion of unesterified [3H]arachidonate in the anesthetized rat. J. Neurochem. 63, 727–736.
Weltzien H. U. (1979) Cytolytic and membrane-perturbing properties of lysophosphatidylcholine. Biochim. Biophys. Acta 559, 259–287.
Wissing D., Mouritzen H., Egeblad M., Poirier G. G., and Jäättelä M. (1997) Involvement of caspase-dependent activation of cytosolic phospholipase A2 in tumor necrosis factor-induced apoptosis. Proc. Natl. Acad. Sci. USA 94, 5073–5077.
Yamashita A., Sugiura T., and Waku K. (1997) Acyltransferases and transacylases involved in fatty acid remodeling of phospholipids and metabolism of bioactive lipids in mammalian cells. J. Biochem. (Tokyo) 122, 1–16.
Yang H. C., Mosior M., Ni B., and Dennis E. A. (1999) Regional distribution, ontogeny, purification, and characterization of the Ca2+-independent phospholipase A2 from rat brain. J. Neurochem. 73, 1278–1287.
Yoshihara Y. and Watanabe Y. (1990) Translocation of phospholipase A2 from cytosol to membranes in rat brain induced by calcium ions. Biochem. Biophys. Res. Commun. 170, 484–490.
Zaleska M. M. and Wilson D. F. (1989) Lipid hydroperoxides inhibit reacylation of phospholipids in neuronal membranes. J. Neurochem. 52, 255–260.
Zaleska M. M. and Wilson D. F. (1992) Effect of hydroperoxy fatty acids on acylation and deacylation of arachidonoyl groups in synaptic phospholipids. J. Neurochem. 58, 107–115.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Farooqui, A.A., Horrocks, L.A. & Farooqui, T. Deacylation and reacylation of neural membrane glycerophospholipids. J Mol Neurosci 14, 123–135 (2000). https://doi.org/10.1385/JMN:14:3:123
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/JMN:14:3:123